Onychomycosis caused by Fusarium sp in Sri Lanka: Prevalence, clinical features and response to itraconazole pulse therapy in six cases

Journal of Dermatological Treatment

Volumn 19, Issue 5, 2008, Pages 308-312

  Ranawaka, Ranthilaka R ^a,c   De Silva, Nelun ^b   Ragunathan, Ramya W ^a  

^a Teaching Hospital Karapitiya   (Sri Lanka)

^b UNIVERSITY OF RUHUNA   (Sri Lanka)

^c NONE   (Sri Lanka)

Author keywords

Fusarium onychomycosis; Itraconazole pulse

Indexed keywords

ITRACONAZOLE; POTASSIUM HYDROXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; FUSARIUM; HUMAN; MALE; MICROSCOPY; ONYCHOMYCOSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SRI LANKA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; COHORT STUDIES; FEMALE; FOOT DERMATOSES; FUSARIUM; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PREVALENCE; SRI LANKA;

EID: 51049090373     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630801974912     Document Type: Article

References (25)

1. Arrese JE, Pierard-Franchimont C, Greimers R, Pierard GE. Fungi in onychomycosis. A study by immunohistochemistry and dual flowcytometry. J Eur Acad Dermatol Venereol. 1995;4:123-30.
2. Midgley G, Moore MK, Cook JC, et al. Mycology of nail disorders. J Am Acad Dermatol. 1994;31:S68-S74.
3. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol. 1998;139:567-71.
4. Haneke E, Roseeuw D. The scope of onychomycosis: Epidemiology and clinical features. Int J Dermatol. 1999;38:7-12.
5. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by non dermatophyte molds: Clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42(2pt1):217-24.
6. Guilhermetti E, Takahachi G, Shinobu CS, Svidzinski TI. Fusarium spp as agents of onychomycosis in immunocompetent hosts. Int J Dermatol. 2007;46:822-6.
7. Calado NB, Sousa F Jr, Gomes NO, Cardoso FR, Zaror LC, Milan EP. Fusarium nail and skin infection: A report of eight cases from Natal, Brazil. Mycopathologia. 2006 Jan;161(1):27-31.
8. Hattori N, Shirai A, Sugiura Y, Li W, Yokoyama K, Misawa Y, et al. Onychomycosis caused by Fusarium proliferatum. Br J Dermatol. 2005 Sep;153(3):647-9.
9. Gianni C, Cerri A, Crosti C. Non-dermatophytic onychomycosis. An underestimated entity? A study of 51 cases. Mycoses. 2000;43:29-33.
10. Greer DL. Evolving role of non dermatophyte molds in onychomycosis. Int J Dermatol. 1995;34:521-9.
11. De Silva N, Perera R. Mycology of nail disorders in Sri Lanka. Colombo: Sri Lanka Medical Association, March 1997. p. OP30.
12. Ramani R, Srinivas CR, Ramani A, Kumari TG, Shivananda PG. Molds in onychomycosis. Int J Dermatol. 1993 Dec;32(12):877-8.
13. English MP. Invasion of the skin by filamentous non-dermatophyte fungi. Br J Dermatol. 1968;80:282-6.
14. De Doncker PR, Scher RK, Baran RL, Decroix J, Degreef HJ, Roseeuw DI, et al. Itraconazole therapy is effective for pedal onychomycosis caused by some non dermatophyte molds and in mixed infection with dermatophytes and molds; A multicenter study with 36 patients. J Am Acad Dermatol. 1997;36(2 pt 1):173-7.
15. De Doncker PR, Gupta AK, Marynissen G, et al. Itraconazole pulse therapy for onychomycosis and dermatomycosis: An overview. J Am Acad Dermatol. 1997;37:969-74.
16. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin. 2003;21:491-7.
17. Gupta AK, Gregurek-Novok T, Konnikov N, Lynde CW, Hofstader S, Summerbell RC. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. J Cutan Med Surg. 2001 May-Jun;5(3):206-10.
18. James Q, Del Rosso DO, Gupta AK. The use of intermittent itraconazole therapy for superficial mycotic infections: A review and update on the 'one week' approach. Int J Dermatol. 1999;38(suppl 2):28-39.
19. Gupta AK, De Doncker IR, Scher RK. Itraconazole for the treatment of onychomycosis. Int J Dermatol. 1998;37:303-8.
20. De Doncker P. Pharmacokinetics of orally administered antifungals in onychomycosis. Int J Dermatol. 1999;38(suppl 2):20-7.
21. Del Rosso JQ, Gupta AK, Optimising treatment with oral antifungal agents. Poster presentation at the annual AAD, March 1998, Orlando, USA.
22. Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002 Nov;47(5):659-66.
23. Baran R, Tosti A, Piraccini BM. Uncommon clinical patterns of Fusarium nail infection. Br J Dermatol. 1997;136:424-7.
24. Gianni C, Cerri A, Crosti C. Unusual clinical features of fingernail infection by Fusarium oxysporum. Mycoses. 1997;40(11-12):455-9.
25. Bokhari MA, Hussain I, Jahangir M, Haroon TS, Aman S, Khurshid K. Onychomycosis in Lahore, Pakistan. Int J Dermatol. 1999 Aug;38(8):591-5.